Revenue
No reported data
PSYENCE BIOMEDICAL LTD. (PBM)
Price—Loading quote
Net income
2023
2024
2025
Free cash flow
2024
2025
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Research & development | $342,168 | $954,593 | $1.6M |
| Net income | $1.0M | −$51.2M | −$3.2M |
| Basic EPSper diluted share | $5.24 | -$4,674.25 | -$394.06 |
| Diluted EPSper diluted share | $5.24 | -$4,674.25 | -$394.06 |